|
Real-time Estimate
Cboe BZX
01:27:29 2026-10-28 pm EDT
|
5-day change | 1st Jan Change | ||
| 10.05 USD | -0.50% |
|
+9.28% | +30.38% |
| Oct. 15 | Verastem's G12D Drug Shows Promise in Pancreatic Cancer, Shares Undervalued, RBC Says | MT |
| Oct. 15 | Mizuho Raises Price Target on Verastem to $14 From $13, Keeps Outperform Rating | MT |
| Market Cap | 1.23B 1.1B 1.02B 922M 1.72B 117B 1.74B 12.17B 4.85B 61.16B 4.61B 4.51B 194B | P/E 2026 * |
-6.24x | P/E 2027 * | -7.57x |
|---|---|---|---|---|---|
| Enterprise Value | 1.04B 932M 862M 780M 1.46B 98.94B 1.48B 10.3B 4.1B 51.77B 3.9B 3.82B 164B | EV / Sales 2026 * |
9.33x | EV / Sales 2027 * | 7.71x |
| Free-Float |
99.19% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VSTM | Delayed | |
CBOE
| VSTM | Real-time | |
Deutsche Boerse AG
| 2VSA | Delayed | |
Tradegate
| 2VSA | Real-time | |
Boerse Muenchen
| 2VSA | Real-time | |
Börse Stuttgart
| 2VSA | Delayed |
Last Transcript: Verastem, Inc.
| 1 day | -0.50% | ||
| 1 week | +9.28% | ||
| Current month | +25.03% | ||
| 1 month | +29.54% | ||
| 3 months | +61.56% | ||
| 6 months | +84.34% | ||
| Current year | +30.38% |
| 1 week | 9.14 | 10.25 | |
| 1 month | 6.7 | 10.25 | |
| Current year | 3.43 | 10.25 | |
| 1 year | 3.43 | 10.82 | |
| 3 years | 2.1 | 14.22 | |
| 5 years | 2.1 | 39.6 | |
| 10 years | 2.1 | 124.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dan Paterson
CEO | Chief Executive Officer | 65 | 2023-07-31 |
Daniel Calkins
DFI | Director of Finance/CFO | 39 | 2022-10-30 |
John Hayslip
CTO | Chief Tech/Sci/R&D Officer | - | 2024-04-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Kauffman
CHM | Chairman | 62 | - |
Dan Paterson
BRD | Director/Board Member | 65 | 2023-07-31 |
Eric Rowinsky
BRD | Director/Board Member | 69 | 2017-05-02 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Sell | Chief Financial Officer | -2,566 | 0.0042% | ||
| 10/1/26 | Sell | Chief Executive Officer | -44,121 | 0.0717% | ||
| 9/21/26 | Sell | Chief Financial Officer | -55 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.50% | +9.28% | +13.73% | +61.82% | 1.23B | ||
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | ||
| +1.76% | +1.27% | +11.82% | +82.12% | 54.55B | ||
| -0.94% | +0.99% | +10.45% | +102.18% | 53.59B | ||
| +1.91% | -0.03% | +26.78% | +56.10% | 44.75B | ||
| +2.30% | -3.21% | +18.05% | +100.44% | 41.62B | ||
| +0.38% | -3.88% | +221.02% | +917.66% | 39.91B | ||
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | ||
| +29.06% | +47.63% | +107.12% | +94.27% | 26.7B | ||
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | ||
| Average | +3.88% | +0.44% | +47.85% | +151.77% | 38.17B | |
| Weighted average by Cap. | +3.03% | -0.26% | +46.98% | +160.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 111M 99.86M 92.32M 83.61M 156M 10.6B 158M 1.1B 440M 5.55B 418M 409M 17.61B | 159M 143M 132M 120M 223M 15.16B 226M 1.58B 629M 7.93B 597M 585M 25.18B |
| Net income | -170M -153M -141M -128M -239M -16.23B -242M -1.69B -673M -8.49B -639M -626M -26.96B | -179M -160M -148M -134M -251M -17.01B -254M -1.77B -705M -8.9B -670M -656M -28.26B |
| Net Debt | -188M -169M -156M -141M -264M -17.93B -267M -1.87B -744M -9.38B -707M -692M -29.79B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | $10.07 | -0.30% | 1,400,001 |
| 26-10-27 | $10.10 | +1.00% | 4,708,399 |
| 26-10-26 | $10.00 | -0.40% | 4,289,252 |
| 26-10-23 | $10.04 | -0.20% | 3,762,126 |
| 26-10-22 | $10.06 | +9.23% | 5,947,460 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VSTM Stock
Select your edition
All financial news and data tailored to specific country editions

















